Laboratory of Human Carcinogenesis, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Blood Cancer J. 2018 Aug 28;8(9):85. doi: 10.1038/s41408-018-0118-z.
Multiple myeloma is a rare plasma cell cancer, and incidence rates among patients of African descent are about twice those among patients of European descent. Rates of multiple myeloma vary among different populations, but the reasons for the racial disparities in multiple myeloma are largely unknown. Epidemiology has identified risk factors for multiple myeloma including race, advanced age, gender, family history, and exposure to different genetic toxins including radiation. Race and ancestry play a large role in predicting the risk for multiple myeloma, yet there exists a paucity of literature that explores the molecular contribution of race and ancestry to disease. In this review, we describe the relevant literature that describes the observed racial differences according to distinct tumor immunobiological and ancestral differences in populations.
多发性骨髓瘤是一种罕见的浆细胞癌,非洲裔患者的发病率约为欧洲裔患者的两倍。多发性骨髓瘤的发病率在不同人群中有所不同,但导致多发性骨髓瘤种族差异的原因在很大程度上尚不清楚。流行病学已经确定了多发性骨髓瘤的风险因素,包括种族、年龄较大、性别、家族史以及接触不同的遗传毒素,如辐射。种族和祖先是预测多发性骨髓瘤风险的重要因素,但目前文献很少探讨种族和祖源对疾病的分子贡献。在这篇综述中,我们描述了相关文献,根据人群中不同的肿瘤免疫生物学和祖源差异描述了观察到的种族差异。